Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Young Adults With Early-onset Obesity Treated With Semaglutide -The RESETTLE Study

NCT05574439 is registered in ClinicalTrials.gov with Signe Torekov as lead sponsor.

NCT NCT05574439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05574439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Young Adults With Early-onset Obesity Treated With Semaglutide -The RESETTLE Study
Lead sponsor
Signe Torekov
Phase
Phase 4
Overall status
Completed
Start date
May 30, 2022
Completion date
April 1, 2026
Enrollment
246 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, adolescent